tirzepatide med class for Weight Loss Compounded GLP-1 - Semaglutide &
Description
Verdict: Draw Both treatments have a similar safety profile with a low risk of serious adverse effects
Key Benefits Mechanism of Action Retatrutide is a triple agonist of GLP-1, GIP, and glucagon receptors
Every reuse dulls the needle tip, increases injection pain, and raises contamination risk
Currently, no human data exist on tirzepatide transfer into breast milk or its effects on nursing infants
Additionally, Zepbound can cause low blood sugar levels, so careful monitoring is crucial
